We discovered that CD47 has high levels in prostate carcinoma and that it is positively connected with prostate cancer invasion, angiogenesis, resting, and proliferation and negatively correlated with DNA repair based on our examination of data from the GEPIA and CancerSEA databases. Here, CD47 is linked to prostate carcinoma.